Humana (NYSE:HUM) Shares Gap Up – Time to Buy?

Humana Inc. (NYSE:HUM)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $210.34, but opened at $221.71. Humana shares last traded at $221.27, with a volume of 403,594 shares changing hands.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HUM. Truist Financial increased their price objective on shares of Humana from $200.00 to $220.00 and gave the company a “hold” rating in a research report on Monday, April 13th. UBS Group reaffirmed a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Barclays lowered their price objective on shares of Humana from $245.00 to $176.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 24th. Oppenheimer set a $250.00 price objective on shares of Humana in a research report on Thursday, February 12th. Finally, The Goldman Sachs Group lowered their price objective on shares of Humana from $215.00 to $158.00 and set a “sell” rating for the company in a research report on Friday, February 13th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $222.09.

Humana Price Performance

The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.00. The firm has a market cap of $26.04 billion, a price-to-earnings ratio of 22.09, a P/E/G ratio of 2.33 and a beta of 0.44. The business’s 50-day moving average price is $183.30 and its two-hundred day moving average price is $229.77.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $32.08 billion. During the same quarter last year, the company earned ($2.16) earnings per share. The business’s quarterly revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, research analysts forecast that Humana Inc. will post 9.05 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.6%. Humana’s dividend payout ratio (DPR) is 36.05%.

Insider Transactions at Humana

In other news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the purchase, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.20% of the stock is owned by company insiders.

Hedge Funds Weigh In On Humana

Several large investors have recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC bought a new position in shares of Humana during the fourth quarter worth about $202,000. Woodline Partners LP grew its position in shares of Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after acquiring an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC grew its position in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after acquiring an additional 452 shares during the last quarter. Cresset Asset Management LLC grew its position in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after acquiring an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd grew its position in shares of Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after acquiring an additional 879 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.